TESTIS CANCER RECURRENT

This adverse event was reported 10 times

These drugs are most commonly taken by patients reporting TESTIS CANCER RECURRENT:

# Drug Count
0 ADALIMUMAB 3
1 ADALIMUMAB-AATY 2
2 ADALIMUMAB-ADAZ 2
3 ADALIMUMAB-FKJP 2
4 FINASTERIDE 2
5 CARBOPLATIN 1
6 CISPLATIN 1
7 CLOZAPINE 1
8 ETOPOSIDE PHOSPHATE 1
9 ISOTRETINOIN 1
See all common drugs associated with TESTIS CANCER RECURRENT

TESTIS CANCER RECURRENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ETOPOSIDE PHOSPHATE 1 0.0006
1 ADALIMUMAB-FKJP 2 0.0000
2 ADALIMUMAB-AATY 2 0.0000
3 ADALIMUMAB-ADAZ 2 0.0000
4 FINASTERIDE 2 0.0000
5 ISOTRETINOIN 1 0.0000
6 CISPLATIN 1 0.0000
7 VEDOLIZUMAB 1 0.0000
8 LEFLUNOMIDE 1 0.0000
9 CLOZAPINE 1 0.0000
See all drugs enriched for association with TESTIS CANCER RECURRENT

TESTIS CANCER RECURRENT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 5-alpha Reductase Inhibitor [EPC] 2 0.0000
1 Integrin Receptor Antagonist [EPC] 1 0.0000
2 Antirheumatic Agent [EPC] 1 0.0000
3 Retinoid [EPC] 1 0.0000
4 Platinum-based Drug [EPC] 1 0.0000
5 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
6 Atypical Antipsychotic [EPC] 1 0.0000
7 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
See all drug classes enriched for association with TESTIS CANCER RECURRENT